Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s Disease
Home
>
News
>
Oligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s Disease
Print
Oligomerix
>
News
>
Oligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s Disease
Oligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s Disease
Post navigation
Previous Post
Oligomerix Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
Next Post
SFN 2010 Press Release: Validation of Extracellular Tau Oligomer Target
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
